Injury guide

Used Hair Relaxers and Have Cancer?

Cancer in an ovary after relaxer use? Keep your exact diagnosis report and product dates.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202614 sources

This may apply to you if

  • List the chemical relaxer or straightener brands you used and your best use dates.
  • Have the report that names your cancer and the diagnosis date ready to discuss.
  • Ask a lawyer to check the product history, claim rules and filing time. The study’s use categories are not a claim cutoff.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Mary M. Rowland · U.S. District Court, Northern District of Illinois · United States District Judge

Finding: The September 24, 2026 court notice schedules the first federal test trial for September 7, 2027. A scheduled test trial is not a payment date or a ruling that every claim succeeds.

Notification of docket entry, Document 2041 (opens in a new tab) · Sep 24, 2026 · Checked Oct 3, 2026

Alexandra J. White · National Institute of Environmental Health Sciences, Epidemiology Branch · First-listed author; journal issue dated October 5, 2021

Finding: The study found a link with frequent reported straightener use in the prior year. Any use in that year was not linked to ovarian cancer in the same analysis. Neither finding proves an individual cause.

White and colleagues: hair products and ovarian cancer (opens in a new tab) · Oct 5, 2021 · Checked Oct 3, 2026

The evidence and its limits

National Institute of Environmental Health Sciences · Carcinogenesis · 2021

Hair products and ovarian cancer in the Sister Study

Design:
Cohort
Participants:
40,559 women aged35–74;241 ovarian diagnoses over mean10years
Finding:
Frequent prior-year straightener/relaxer/pressing use was associated with ovarian cancer; any use in the prior year was not.
Main limitation
Observational self-reported use; association is not individual causation, a named-brand finding or a legal use threshold. Original abstract only.

Read the source: Hair products and ovarian cancer in the Sister Study (opens in a new tab) · Checked Oct 3, 2026

The short answer

What is ovarian cancer?
It is cancer affecting the ovary. There are different types. Ask your care team which type your record names before comparing your case with a study. [12]
What signs should I take to a doctor?
Ask about symptoms that get worse or do not go away. A list of signs cannot diagnose you. A claim inquiry should not delay care. [12]
How is it diagnosed and treated?
Ask your doctor to explain the tests and the final diagnosis. Care depends on the tumor type and how far it has spread. This page does not choose treatment. [12]
What does the original ovarian study show?
It found a link with frequent use in the prior year. Any use that year was not linked in the same study. Neither result proves the cause for one person. [13]

What rules a case out

Not covered by this case

  • Womb-cancer findings cannot be relabeled as ovarian findings.
  • A symptom or one lab result does not confirm ovarian cancer.
  • A study use group does not guarantee a claim will be accepted.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

When it fits this case

  • List the chemical relaxer or straightener brands you used and your best use dates.
  • Have the report that names your cancer and the diagnosis date ready to discuss.
  • Ask a lawyer to check the product history, claim rules and filing time. The study’s use categories are not a claim cutoff.

Cancer in an ovary after relaxer use? Keep your exact diagnosis report and product dates. Your doctor and your lawyer check different things.

What is ovarian cancer?

It is cancer affecting the ovary. There are different types. Ask your care team which type your record names before comparing your case with a study.

The NCI guide here covers cancer in tissue on the ovary, fallopian tube or abdominal lining. It points to separate guides for other ovarian tumors. Its advice should not be silently applied to every tumor type.

What signs should I take to a doctor?

Ask about symptoms that get worse or do not go away. A list of signs cannot diagnose you. A claim inquiry should not delay care.

NCI lists pain, pressure or swelling in the belly or pelvis, trouble eating and other possible signs. They can also have causes other than cancer. Some cancers cause no early symptoms; a clinician must assess your situation.

How is it diagnosed and treated?

Ask your doctor to explain the tests and the final diagnosis. Care depends on the tumor type and how far it has spread. This page does not choose treatment.

The NCI guide describes examination, scans and tissue testing among possible steps. A blood marker can rise for reasons other than cancer. Ask which results establish your diagnosis instead of treating one number as proof.

Request the written diagnosis and discuss it with the care team. An ovarian, fallopian-tube or lining cancer label can matter for care. A broad internet phrase is not a substitute for the actual report.

What does the original ovarian study show?

It found a link with frequent use in the prior year. Any use that year was not linked in the same study. Neither result proves the cause for one person.

The original author abstract describes 40,559 Sister Study participants and 241 ovarian diagnoses over a mean ten years. It excluded women with past ovarian cancer or removal of both ovaries. Participants reported use in the prior year.

Frequent straightener, relaxer or pressing-product use was associated with cancer in that analysis. Do not turn that group into a minimum-use legal rule. The uterine study is a different analysis with a different outcome.

Who may qualify for a claim check?

Ask a lawyer to check your product, diagnosis, dates and law. A research finding does not say a firm will accept your case. Keep unknown details marked as unknown.

The transfer order records allegations of reproductive cancer and other harm; it does not decide fault. A coordinated federal case is not automatically one class action or a payment program.

Give the lawyer the exact cancer type and the places where you used products and received care. Ask for the deadline that applies to your proposed claim, rather than using a future test-trial date.

Which records should I gather?

Keep diagnosis and test reports you already have. List product names, use dates and care providers. Ask how to request missing records; do not fill gaps with guesses.

Federal access rules have exceptions and do not promise every old record still exists. Ask each provider what it keeps. Before legal work begins, read the firm’s fee and expense terms and ask what a loss could cost.

Scientific evidence for this case

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Ask a law firm to review your case

Questions about this guide

How is ovarian cancer from hair relaxers different from talcum powder ovarian cancer?

Both involve consumer products marketed to women causing ovarian cancer through chronic exposure. The mechanism differs: talcum powder is believed to cause inflammation through direct application to the genital area, while hair relaxer EDCs are absorbed through the scalp and disrupt hormones systemically.

I was diagnosed with ovarian cancer but also used talcum powder. Can I still file?

Yes. You can potentially pursue claims in both the hair relaxer and talcum powder litigations. Each product's contribution to your cancer risk is a separate legal question. Your attorney can help determine whether to file in one or both litigations. Multiple exposure sources do not eliminate any individual defendant's liability.

Is ovarian cancer from hair relaxers harder to prove than uterine cancer?

The uterine cancer evidence (HR 2.55) is somewhat stronger than the ovarian cancer evidence (HR 2.19) in terms of hazard ratio. However, both are statistically significant.

Sources

  1. Court docket notice 2041, September 24, 2026 (primary court-document mirror)Court docket notice 2041, September 24, 2026 (primary court-document mirror) · court
  2. JPML transfer order, February 6, 2023JPML transfer order, February 6, 2023 · court
  3. Chang et al.: original study abstract, 2022Chang et al.: original study abstract, 2022 · study
  4. JPML pending actions report, October 1, 2026 (cached primary PDF)JPML pending actions report, October 1, 2026 (cached primary PDF) · court
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. Court guide: filing time limitsCourt guide: filing time limits · court
  7. Health-record access, 45 CFR 164.524Health-record access, 45 CFR 164.524 · regulator
  8. JNCI 2022 original author abstract via PubMedNational Library of Medicine · study
  9. Hair Relaxer Use and Risk of Uterine Cancer in the Black Women's Health StudyEnvironmental Research · 2023 · study
  10. Use of Hair Products in Relation to Ovarian Cancer RiskCarcinogenesis · 2021 · study
  11. Scheduling posture in MDL-3060 (N.D. Ill., Judge Mary Rowland): the court took direct control of bellwether selection (April 2026), scrapping the party alternating-picks system; bellwether fact discovery closed June 10, 2026; case-specific Daubert and summary judgment motions due Nov 16, 2026; first trials broadly expected 2027. 11,877 cases pending as of July 1, 2026 (fourth-largest MDL). No verdicts or settlements yet. CAVEAT: documented only via litigation-tracker blogs (llamalab.ai, mdlupdate.com) — last-resort sources, no court record or major-press confirmation fetched.llamalab.ai · Jul 1, 2026 · court
  12. NCI: Ovarian Epithelial Cancer Patient Guide
  13. White and colleagues: hair products and ovarian cancer
  14. NCI: How Cancer Is DiagnosedNCI: How Cancer Is Diagnosed · regulator

Checked against 13 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026